From the BRCA1 study, differentially methylated CpGs, with false discovery rate (FDR) corrected P values, between BRCA1 mutant carriers and BRCA1 wild type samples were identified via a multivariate logistic regression that was adjusted for age, batch and the presence of cancer. Here, BRCA1 is linked to cancer.